Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.1 (
ERK
)
95,504
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Damaging
GATA6
variants cause cardiac outflow tract defects, sometimes with pancreatic and diaphragmic malformations. To define molecular mechanisms for these diverse developmental defects, we studied transcriptional and epigenetic responses to
GATA6
loss of function (LoF) and missense variants during cardiomyocyte differentiation of isogenic human induced pluripotent stem cells. We show that GATA6 is a pioneer factor in cardiac development, regulating
SMYD1
that activates
HAND2,
and
KDR
that with
HAND2
orchestrates outflow tract formation. LoF variants perturbed cardiac genes and also endoderm lineage genes that direct
PDX1
expression and pancreatic development. Remarkably, an exon 4
GATA6
missense variant, highly associated with extra-cardiac malformations, caused ectopic pioneer activities, profoundly diminishing
GATA4
,
FOXA1
/2,
and
PDX1
expression and increasing normal retinoic acid signaling that promotes diaphragm development. These aberrant epigenetic and transcriptional signatures illuminate the molecular mechanisms for cardiovascular malformations, pancreas and diaphragm dysgenesis that arise in patients with distinct
GATA6
variants.
...
PMID:
GATA6
mutations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm. 3305 71
<< Previous
1
2
3
4
5
6